Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.

Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study

Open access

Abstract

Background: Immune anomalies have been documented in individuals with autism spectrum disorders (ASDs) and their family members. It is unknown whether the maternal immune profile during pregnancy is associated with the risk of bearing a child with ASD or other neurodevelopmental disorders. Methods: Using Luminex technology, levels of 17 cytokines and chemokines were measured in banked serum collected from women at 15 to 19 weeks of gestation who gave birth to a child ultimately diagnosed with (1) ASD ( n = 84), (2) a developmental delay (DD) but not autism ( n = 49) or (3) no known developmental disability (general population (GP); n = 159). ASD and DD risk associated with maternal cytokine and chemokine levels was estimated by using multivariable logistic regression analysis. Results: Elevated concentrations of IFN-γ, IL-4 and IL-5 in midgestation maternal serum were significantly associated with a 50% increased risk of ASD, regardless of ASD onset type and the presence of intellectual disability. By contrast, elevated concentrations of IL-2, IL-4 and IL-6 were significantly associated with an increased risk of DD without autism. Conclusion: The profile of elevated serum IFN-γ, IL-4 and IL-5 was more common in women who gave birth to a child subsequently diagnosed with ASD. An alternative profile of increased IL-2, IL-4 and IL-6 was more common for women who gave birth to a child subsequently diagnosed with DD without autism. Further investigation is needed to characterize the relationship between these divergent maternal immunological phenotypes and to evaluate their effect on neurodevelopment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/2040-2392-2-13

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Midgestational serum IFN-γ. Scatterplots of natural log-transformed levels of serum IFN-γ in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.
Figure 1 Midgestational serum IFN-γ. Scatterplots of natural log-transformed levels of serum IFN-γ in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.CC BY · PubMed Central
Figure 2 Midgestational serum IL-4. Scatterplots of natural log-transformed levels of serum IL-4 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.
Figure 2 Midgestational serum IL-4. Scatterplots of natural log-transformed levels of serum IL-4 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.CC BY · PubMed Central
Figure 3 Midgestational serum IL-5. Scatterplots of natural log-transformed levels of serum IL-5 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.
Figure 3 Midgestational serum IL-5. Scatterplots of natural log-transformed levels of serum IL-5 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.CC BY · PubMed Central
Figure 4 Midgestational serum IL-6. Scatterplots of natural log-transformed levels of serum IL-6 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.
Figure 4 Midgestational serum IL-6. Scatterplots of natural log-transformed levels of serum IL-6 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.CC BY · PubMed Central
Figure 5 Midgestational serum IL-2. Scatterplots of natural log-transformed levels of serum IL-2 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.
Figure 5 Midgestational serum IL-2. Scatterplots of natural log-transformed levels of serum IL-2 in mothers bearing a child with autism spectrum disorder (AU) or a developmental disability other than ASD (DD) compared with a general population control (GP). Each dot represents a single individual. Bars represent the medians and interquartile ranges.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 61 references

Cited by

See all 367

Metadata

Authors
Goines, P. E., Croen, L. A., Braunschweig, D., Yoshida, C. K., Grether, J., Hansen, R., Kharrazi, M., Ashwood, P., & Van de Water, J.
Affiliations
  • University of California, Davis (US)
  • Kaiser Permanente (US)
  • California Department of Public Health (US)
Venue
Molecular Autism
Published
2011-08-02
Volume
2
Issue
1
Pages
13-13
ISSN
2040-2392 (ISSN-L)
OpenAlex
W2137386978
Cited by
351
References
61
Citations by year
2026: 15 · 2025: 15 · 2024: 29 · 2023: 30 · 2022: 29 · 2021: 21 · 2020: 36 · 2019: 26 · 2018: 29 · 2017: 20 · 2016: 23 · 2015: 21 · 2014: 19 · 2013: 18 · 2012: 18
FWCI
9.26
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Molecular Autism (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Autism Speaks (AS2514)
  • U.S. Environmental Protection Agency (R-829388)
  • California Department of Public Health
  • Tobacco-Related Disease Research Program (8RT‐0115)
  • National Institutes of Health (R829388, ES11269)
  • National Institute of Mental Health
  • National Institute of Environmental Health Sciences (R01ES016669)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
Keywords
autism spectrum disorder, developmental delay, interferon-gamma, IL-4, IL-5, interleukin-2, interleukin-6, chemokines, neurodevelopmental risk, pregnancy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. https://app.cochat.ai/papers/10.1186/2040-2392-2-13
The paper
Goines, P. E., Croen, L. A., Braunschweig, D., Yoshida, C. K., Grether, J., Hansen, R., Kharrazi, M., Ashwood, P., & Van de Water, J. (2011). Increased midgestational IFN-γ, IL-4 and IL-5 in women bearing a child with autism: A case-control study. Molecular Autism. https://doi.org/10.1186/2040-2392-2-13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.